Cholera Vaccine (Oral Route) Market Report

Europe Cholera Vaccine (Oral Route) Market Size, Status and Forecast 2014-2026

  • POSTDATE：Jun 15, 2020
  • PAGES：164
  • REPORT CODE：GMM545800
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Cholera Vaccine (Oral Route) market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 1.6% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Cholera Vaccine (Oral Route) Market Segmentations:

    By Player:

    • Sanofi

    • EuBiologics

    • PaxVax

    • Valneva

    By Type:

    • Shanchol

    • Dukoral

    • Vaxchora

    • Others

    By End-User:

    • Hospital

    • Research & Academic Laboratories

    • Pharmaceutical & Biotechnology Companies

    • Others

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Cholera Vaccine (Oral Route) Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Cholera Vaccine (Oral Route) Market Size and Growth Rate of Shanchol from 2014 to 2026

    • 1.3.2 Europe Cholera Vaccine (Oral Route) Market Size and Growth Rate of Dukoral from 2014 to 2026

    • 1.3.3 Europe Cholera Vaccine (Oral Route) Market Size and Growth Rate of Vaxchora from 2014 to 2026

    • 1.3.4 Europe Cholera Vaccine (Oral Route) Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Cholera Vaccine (Oral Route) Market Size and Growth Rate of Hospital from 2014 to 2026

    • 1.4.2 Europe Cholera Vaccine (Oral Route) Market Size and Growth Rate of Research & Academic Laboratories from 2014 to 2026

    • 1.4.3 Europe Cholera Vaccine (Oral Route) Market Size and Growth Rate of Pharmaceutical & Biotechnology Companies from 2014 to 2026

    • 1.4.4 Europe Cholera Vaccine (Oral Route) Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Cholera Vaccine (Oral Route) Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Cholera Vaccine (Oral Route) by Major Types

      • 3.4.1 Market Size and Growth Rate of Shanchol

      • 3.4.2 Market Size and Growth Rate of Dukoral

      • 3.4.3 Market Size and Growth Rate of Vaxchora

      • 3.4.4 Market Size and Growth Rate of Others

    4 Segmentation of Cholera Vaccine (Oral Route) Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Cholera Vaccine (Oral Route) by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Hospital for Construction

      • 4.4.2 Market Size and Growth Rate of Research & Academic Laboratories for Construction

      • 4.4.3 Market Size and Growth Rate of Pharmaceutical & Biotechnology Companies for Construction

      • 4.4.4 Market Size and Growth Rate of Others for Construction

    5 Market Analysis by Major Regions

    • 5.1 Europe Cholera Vaccine (Oral Route) Production Analysis by Top Regions

    • 5.2 Europe Cholera Vaccine (Oral Route) Consumption Analysis by Top Regions

    • 5.3 Europe Cholera Vaccine (Oral Route) Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Cholera Vaccine (Oral Route) Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Cholera Vaccine (Oral Route) Production, Import, Consumption and Export Analysis

      • 5.3.3 France Cholera Vaccine (Oral Route) Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Cholera Vaccine (Oral Route) Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Cholera Vaccine (Oral Route) Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Cholera Vaccine (Oral Route) Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Cholera Vaccine (Oral Route) Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Cholera Vaccine (Oral Route) Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Cholera Vaccine (Oral Route) Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cholera Vaccine (Oral Route) Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Cholera Vaccine (Oral Route) Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Cholera Vaccine (Oral Route) Production, Import, Consumption and Export Analysis

    6 Product Circulation of Cholera Vaccine (Oral Route) Market among Top Countries

    • 6.1 Top 5 Export Countries in Cholera Vaccine (Oral Route) Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Cholera Vaccine (Oral Route) Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Cholera Vaccine (Oral Route) Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Cholera Vaccine (Oral Route) Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Cholera Vaccine (Oral Route) Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Cholera Vaccine (Oral Route) Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Cholera Vaccine (Oral Route) Landscape Analysis

    • 7.1 Germany Cholera Vaccine (Oral Route) Landscape Analysis by Major Types

    • 7.2 Germany Cholera Vaccine (Oral Route) Landscape Analysis by Major End-Users

    8. UK Cholera Vaccine (Oral Route) Landscape Analysis

    • 8.1 UK Cholera Vaccine (Oral Route) Landscape Analysis by Major Types

    • 8.2 UK Cholera Vaccine (Oral Route) Landscape Analysis by Major End-Users

    9. France Cholera Vaccine (Oral Route) Landscape Analysis

    • 9.1 France Cholera Vaccine (Oral Route) Landscape Analysis by Major Types

    • 9.2 France Cholera Vaccine (Oral Route) Landscape Analysis by Major End-Users

    10. Italy Cholera Vaccine (Oral Route) Landscape Analysis

    • 10.1 Italy Cholera Vaccine (Oral Route) Landscape Analysis by Major Types

    • 10.2 Italy Cholera Vaccine (Oral Route) Landscape Analysis by Major End-Users

    11. Spain Cholera Vaccine (Oral Route) Landscape Analysis

    • 11.1 Spain Cholera Vaccine (Oral Route) Landscape Analysis by Major Types

    • 11.2 Spain Cholera Vaccine (Oral Route) Landscape Analysis by Major End-Users

    12. Poland Cholera Vaccine (Oral Route) Landscape Analysis

    • 12.1 Poland Cholera Vaccine (Oral Route) Landscape Analysis by Major Types

    • 12.2 Poland Cholera Vaccine (Oral Route) Landscape Analysis by Major End-Users

    13. Russia Cholera Vaccine (Oral Route) Landscape Analysis

    • 13.1 Russia Cholera Vaccine (Oral Route) Landscape Analysis by Major Types

    • 13.2 Russia Cholera Vaccine (Oral Route) Landscape Analysis by Major End-Users

    14. Switzerland Cholera Vaccine (Oral Route) Landscape Analysis

    • 14.1 Switzerland Cholera Vaccine (Oral Route) Landscape Analysis by Major Types

    • 14.2 Switzerland Cholera Vaccine (Oral Route) Landscape Analysis by Major End-Users

    15. Turkey Cholera Vaccine (Oral Route) Landscape Analysis

    • 15.1 Turkey Cholera Vaccine (Oral Route) Landscape Analysis by Major Types

    • 15.2 Turkey Cholera Vaccine (Oral Route) Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cholera Vaccine (Oral Route) Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cholera Vaccine (Oral Route) Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cholera Vaccine (Oral Route) Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cholera Vaccine (Oral Route) Landscape Analysis by Top Countries

      • 16.3.1 Denmark Cholera Vaccine (Oral Route) Market Volume and Growth Rate

      • 16.3.2 Finland Cholera Vaccine (Oral Route) Market Volume and Growth Rate

      • 16.3.3 Norway Cholera Vaccine (Oral Route) Market Volume and Growth Rate

      • 16.3.4 Sweden Cholera Vaccine (Oral Route) Market Volume and Growth Rate

      • 16.3.6 Iceland Cholera Vaccine (Oral Route) Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Cholera Vaccine (Oral Route) Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Cholera Vaccine (Oral Route) Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Cholera Vaccine (Oral Route) Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Cholera Vaccine (Oral Route) Landscape Analysis by Top Countries

      • 17.3.1 Belgium Cholera Vaccine (Oral Route) Market Volume and Growth Rate

      • 17.3.2 Netherlands Cholera Vaccine (Oral Route) Market Volume and Growth Rate

      • 17.3.3 Luxembourg Cholera Vaccine (Oral Route) Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Cholera Vaccine (Oral Route) Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Cholera Vaccine (Oral Route) Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Cholera Vaccine (Oral Route) Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Cholera Vaccine (Oral Route) Landscape Analysis by Top Countries

      • 18.3.1 Estonia Cholera Vaccine (Oral Route) Market Volume and Growth Rate

      • 18.3.2 Latvia Cholera Vaccine (Oral Route) Market Volume and Growth Rate

      • 18.3.3 Lithuania Cholera Vaccine (Oral Route) Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Sanofi

      • 19.1.1 Sanofi Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 EuBiologics

      • 19.2.1 EuBiologics Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 PaxVax

      • 19.3.1 PaxVax Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Valneva

      • 19.4.1 Valneva Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    The List of Tables and Figures (Totals 77 Figures and 161 Tables)

    • Figure Product Picture

    • Figure Cholera Vaccine (Oral Route) Market Size and Growth Rate of Shanchol Market, 2015 - 2026 (USD Million)

    • Figure Cholera Vaccine (Oral Route) Market Size and Growth Rate of Dukoral Market, 2015 - 2026 (USD Million)

    • Figure Cholera Vaccine (Oral Route) Market Size and Growth Rate of Vaxchora Market, 2015 - 2026 (USD Million)

    • Figure Cholera Vaccine (Oral Route) Market Size and Growth Rate of Others Market, 2015 - 2026 (USD Million)

    • Figure Cholera Vaccine (Oral Route) Market Size and Growth Rate of Hospital from 2014 to 2026

    • Figure Cholera Vaccine (Oral Route) Market Size and Growth Rate of Research & Academic Laboratories from 2014 to 2026

    • Figure Cholera Vaccine (Oral Route) Market Size and Growth Rate of Pharmaceutical & Biotechnology Companies from 2014 to 2026

    • Figure Cholera Vaccine (Oral Route) Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Germany Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure UK Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure France Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Cholera Vaccine (Oral Route) Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Cholera Vaccine (Oral Route)

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Cholera Vaccine (Oral Route) by Different Types from 2014 to 2026

    • Table Consumption Share of Cholera Vaccine (Oral Route) by Different Types from 2014 to 2026

    • Figure Cholera Vaccine (Oral Route) Market Size and Growth Rate of Shanchol Market, 2015 - 2026 (USD Million)

    • Figure Cholera Vaccine (Oral Route) Market Size and Growth Rate of Dukoral Market, 2015 - 2026 (USD Million)

    • Figure Cholera Vaccine (Oral Route) Market Size and Growth Rate of Vaxchora Market, 2015 - 2026 (USD Million)

    • Figure Cholera Vaccine (Oral Route) Market Size and Growth Rate of Others Market, 2015 - 2026 (USD Million)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Cholera Vaccine (Oral Route) by Different End-Users from 2014 to 2026

    • Table Consumption Share of Cholera Vaccine (Oral Route) by Different End-Users from 2014 to 2026

    • Figure Cholera Vaccine (Oral Route) Market Size and Growth Rate of Hospital from 2014 to 2026

    • Figure Cholera Vaccine (Oral Route) Market Size and Growth Rate of Research & Academic Laboratories from 2014 to 2026

    • Figure Cholera Vaccine (Oral Route) Market Size and Growth Rate of Pharmaceutical & Biotechnology Companies from 2014 to 2026

    • Figure Cholera Vaccine (Oral Route) Market Size and Growth Rate of Others from 2014 to 2026

    • Table Europe Cholera Vaccine (Oral Route) Production by Major Regions

    • Table Europe Cholera Vaccine (Oral Route) Production Share by Major Regions

    • Figure Europe Cholera Vaccine (Oral Route) Production Share by Major Countries and Regions in 2014

    • Table Europe Cholera Vaccine (Oral Route) Consumption by Major Regions

    • Table Europe Cholera Vaccine (Oral Route) Consumption Share by Major Regions

    • Table Germany Cholera Vaccine (Oral Route) Production, Import, Consumption and Export Analysis

    • Table UK Cholera Vaccine (Oral Route) Production, Import, Consumption and Export Analysis

    • Table France Cholera Vaccine (Oral Route) Production, Import, Consumption and Export Analysis

    • Table Italy Cholera Vaccine (Oral Route) Production, Import, Consumption and Export Analysis

    • Table Spain Cholera Vaccine (Oral Route) Production, Import, Consumption and Export Analysis

    • Table Poland Cholera Vaccine (Oral Route) Production, Import, Consumption and Export Analysis

    • Table Russia Cholera Vaccine (Oral Route) Production, Import, Consumption and Export Analysis

    • Table Switzerland Cholera Vaccine (Oral Route) Production, Import, Consumption and Export Analysis

    • Table Turkey Cholera Vaccine (Oral Route) Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cholera Vaccine (Oral Route) Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Cholera Vaccine (Oral Route) Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Cholera Vaccine (Oral Route) Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Cholera Vaccine (Oral Route) Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Cholera Vaccine (Oral Route) Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Cholera Vaccine (Oral Route) Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Cholera Vaccine (Oral Route) Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Cholera Vaccine (Oral Route) Consumption by Types from 2014 to 2026

    • Table Germany Cholera Vaccine (Oral Route) Consumption Share by Types from 2014 to 2026

    • Table Germany Cholera Vaccine (Oral Route) Consumption by End-Users from 2014 to 2026

    • Table Germany Cholera Vaccine (Oral Route) Consumption Share by End-Users from 2014 to 2026

    • Table UK Cholera Vaccine (Oral Route) Consumption by Types from 2014 to 2026

    • Table UK Cholera Vaccine (Oral Route) Consumption Share by Types from 2014 to 2026

    • Table UK Cholera Vaccine (Oral Route) Consumption by End-Users from 2014 to 2026

    • Table UK Cholera Vaccine (Oral Route) Consumption Share by End-Users from 2014 to 2026

    • Table France Cholera Vaccine (Oral Route) Consumption by Types from 2014 to 2026

    • Table France Cholera Vaccine (Oral Route) Consumption Share by Types from 2014 to 2026

    • Table France Cholera Vaccine (Oral Route) Consumption by End-Users from 2014 to 2026

    • Table France Cholera Vaccine (Oral Route) Consumption Share by End-Users from 2014 to 2026

    • Table Italy Cholera Vaccine (Oral Route) Consumption by Types from 2014 to 2026

    • Table Italy Cholera Vaccine (Oral Route) Consumption Share by Types from 2014 to 2026

    • Table Italy Cholera Vaccine (Oral Route) Consumption by End-Users from 2014 to 2026

    • Table Italy Cholera Vaccine (Oral Route) Consumption Share by End-Users from 2014 to 2026

    • Table Spain Cholera Vaccine (Oral Route) Consumption by Types from 2014 to 2026

    • Table Spain Cholera Vaccine (Oral Route) Consumption Share by Types from 2014 to 2026

    • Table Spain Cholera Vaccine (Oral Route) Consumption by End-Users from 2014 to 2026

    • Table Spain Cholera Vaccine (Oral Route) Consumption Share by End-Users from 2014 to 2026

    • Table Poland Cholera Vaccine (Oral Route) Consumption by Types from 2014 to 2026

    • Table Poland Cholera Vaccine (Oral Route) Consumption Share by Types from 2014 to 2026

    • Table Poland Cholera Vaccine (Oral Route) Consumption by End-Users from 2014 to 2026

    • Table Poland Cholera Vaccine (Oral Route) Consumption Share by End-Users from 2014 to 2026

    • Table Russia Cholera Vaccine (Oral Route) Consumption by Types from 2014 to 2026

    • Table Russia Cholera Vaccine (Oral Route) Consumption Share by Types from 2014 to 2026

    • Table Russia Cholera Vaccine (Oral Route) Consumption by End-Users from 2014 to 2026

    • Table Russia Cholera Vaccine (Oral Route) Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Cholera Vaccine (Oral Route) Consumption by Types from 2014 to 2026

    • Table Switzerland Cholera Vaccine (Oral Route) Consumption Share by Types from 2014 to 2026

    • Table Switzerland Cholera Vaccine (Oral Route) Consumption by End-Users from 2014 to 2026

    • Table Switzerland Cholera Vaccine (Oral Route) Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Cholera Vaccine (Oral Route) Consumption by Types from 2014 to 2026

    • Table Turkey Cholera Vaccine (Oral Route) Consumption Share by Types from 2014 to 2026

    • Table Turkey Cholera Vaccine (Oral Route) Consumption by End-Users from 2014 to 2026

    • Table Turkey Cholera Vaccine (Oral Route) Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cholera Vaccine (Oral Route) Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cholera Vaccine (Oral Route) Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cholera Vaccine (Oral Route) Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cholera Vaccine (Oral Route) Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cholera Vaccine (Oral Route) Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cholera Vaccine (Oral Route) Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Cholera Vaccine (Oral Route) Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Cholera Vaccine (Oral Route) Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Cholera Vaccine (Oral Route) Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Cholera Vaccine (Oral Route) Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Cholera Vaccine (Oral Route) Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Cholera Vaccine (Oral Route) Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Cholera Vaccine (Oral Route) Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Cholera Vaccine (Oral Route) Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Cholera Vaccine (Oral Route) Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Cholera Vaccine (Oral Route) Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Cholera Vaccine (Oral Route) Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Cholera Vaccine (Oral Route) Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

    • Table Sanofi Profiles

    • Table Sanofi Production, Value, Price, Gross Margin 2014-2019

    • Table Sanofi Product benchmarking

    • Table Sanofi Strategic initiatives

    • Table Sanofi SWOT analysis

    • Table EuBiologics Profiles

    • Table EuBiologics Production, Value, Price, Gross Margin 2014-2019

    • Table EuBiologics Product benchmarking

    • Table EuBiologics Strategic initiatives

    • Table EuBiologics SWOT analysis

    • Table PaxVax Profiles

    • Table PaxVax Production, Value, Price, Gross Margin 2014-2019

    • Table PaxVax Product benchmarking

    • Table PaxVax Strategic initiatives

    • Table PaxVax SWOT analysis

    • Table Valneva Profiles

    • Table Valneva Production, Value, Price, Gross Margin 2014-2019

    • Table Valneva Product benchmarking

    • Table Valneva Strategic initiatives

    • Table Valneva SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US